Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deathsPaul Bastard, Luisa Imberti, Karita Särekannu et al.|Science Immunology|2021Cited by 638
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodiesJérémy Manry, Luisa Imberti, Paul Bastard et al.|Proceedings of the National Academy of Sciences|2022Cited by 198
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in childrenPaul Bastard, Carolina Prando, Adrian Gervais et al.|The Journal of Experimental Medicine|2024Cited by 43
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodiesJérémy Manry, Luisa Imberti, Paul Bastard et al.|Research Square|2022Cited by 24
[50 years of the Neonatal Screening Program in Catalonia.]José Luis Marín Soria, Pere Soler‐Palacín, Rosa Ma López Galera et al.|PubMed|2020Cited by 7